Abiopharma

News list

Hargarten Christina 🟡 adjusted position in 0 shares (1 derivative) of RH (RH) Transaction Date: Mar 30, 2026 | Filing ID: 000002

Full text

News bot April 2, 2026, 12:22 a.m.
🔍 Hargarten Christina (Executive)

Company: RH (RH)

Report Date: 2026-03-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,125
- Total shares sold: 1,125
Detailed Transactions and Holdings:
- Acquired 1,125 shares of Common Stock (Direct)
  Date: 2026-03-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,359.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,125 shares of Restricted Stock Unit (RSU) (Derivative)
  Date: 2026-03-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,125.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of RH common stock.
- F2: On January 31, 2022, the reporting person was granted 7,500 restricted stock units. This restricted stock unit award vested with respect to 10% of the units on each of March 30, 2023, March 30, 2024 and March 30, 2025, 15% of the units vested on March 30, 2026, 15% of the units will vest on March 30, 2027, and 20% of the units will vest on each of March 30, 2028 and March 30, 2029, subject to continuous service.